Section Arrow
Quote
NKGN.NASDAQ
- NKGen Biotech
(Financial Status)
Quotes are at least 15-min delayed:2024/05/03 19:25 EDT
Last
 1.43
+0.11 (+8.33%)
Day High 
1.55 
Prev. Close
1.32 
1-M High
2.11 
Volume 
209.57K 
Bid
1.36
Ask
1.53
Day Low
1.32 
Open
1.33 
1-M Low
0.821 
Market Cap 
30.10M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 1.57 
20-SMA 1.38 
50-SMA 1.54 
52-W High 12.88 
52-W Low 0.7802 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.38/--
Enterprise Value
40.03M
Balance Sheet
Book Value Per Share
-2.57
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
JAGXJaguar Health0.318+0.0248+8.46%-- 
VAXXVaxxinity0.1411+0.0369+35.41%-- 
DNAGinkgo Bioworks Holdings0.955+0.0939+10.90%-- 
ARDXArdelyx8.72+1.93+28.42%-- 
IBRXImmunityBio9.15+0.18+2.01%-- 
Quotes are at least 15-min delayed：2024/05/03 19:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.